- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.04. | Prenetics gewinnt NBA-Star Giannis Antetokounmpo als neuen Aktionär und Partner | 5 | Investing.com Deutsch | ||
| 02.04. | Prenetics Global Limited: Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership | 1 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 01.04. | Prenetics Global (PRE) Partners with Superpower on Diagnostics and Supplements | 5 | Insider Monkey | ||
| 24.03. | Prenetics Global Limited: Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation | 3 | GlobeNewswire (USA) | ||
| 06.03. | Prenetics: Aktienrückkaufprogramm über 40 Mio. USD treibt Kurs an | 2 | Investing.com Deutsch | ||
| 06.03. | Prenetics Global Board Authorizes Share Repurchase Program | - | RTTNews | ||
| 06.03. | Prenetics rises on $40M share buyback program | 1 | Seeking Alpha | ||
| 06.03. | Prenetics announces $40M share buyback program | 1 | Investing.com | ||
| 06.03. | Prenetics Global Limited: Prenetics Authorizes $40 Million Share Repurchase Program | 1 | GlobeNewswire (USA) | ||
| 03.03. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.03. | Prenetics executives purchase $1.3M in company shares | 3 | Investing.com | ||
| 23.02. | Prenetics Global Limited: Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours | 1 | GlobeNewswire (USA) | ||
| 18.02. | Prenetics veräußert Insighta-Beteiligung für 70 Millionen US-Dollar an Tencent | 15 | Investing.com Deutsch | ||
| 18.02. | Prenetics Global Limited: Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR in 12 Months, Revenue Surges 480% YoY | 700 | GlobeNewswire (Europe) | Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic... ► Artikel lesen | |
| 17.02. | Prenetics appoints longevity expert Dr. Darshan Shah to board | 3 | Investing.com | ||
| 17.02. | Prenetics Global Limited: Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors | 802 | GlobeNewswire (Europe) | Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 17.02. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.02. | Prenetics Global Limited: Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity | 971 | GlobeNewswire (Europe) | Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026... ► Artikel lesen | |
| 15.02. | Quant snapshot: IAMGOLD, Prenetics lead strong buys as Sol Strategies, Endava lag | 18 | Seeking Alpha |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 631,90 | -1,06 % | Piper Sandler reiterates Overweight rating on Regeneron stock at $875 | ||
| VIKING THERAPEUTICS | 28,950 | -0,86 % | Viking Therapeutics, Inc.: Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 | 78-Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 Diabetes
SAN DIEGO, March 26, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking)... ► Artikel lesen | |
| CANSINO BIOLOGICS | 3,612 | -0,50 % | CanSino Biologics Inc: CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader | HONG KONG, Mar 31, 2026 - (ACN Newswire) - HONG KONG, Mar 31, 2026 - (ACN Newswire) - China's 2026 Report on the Work of the Government identified biopharmaceuticals as an emerging pillar industry,... ► Artikel lesen | |
| SINO BIOPHARM | 0,630 | -0,74 % | SBP GROUP (01177): VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN THE PHASE II CLINICAL TRIAL OF KYLO-11 "LPA SIRNA" IN THE ... | ||
| GUARDANT HEALTH | 67,16 | 0,00 % | Wachstum bei Krebstests: Canaccord bestätigt Kaufempfehlung für Guardant Health | ||
| BIO-TECHNE | 47,000 | -0,42 % | April McClain Delaney makes multiple trades in Bio-Techne, BJ's Wholesale, and Nasdaq | ||
| GENSCRIPT BIOTECH | 1,430 | +5,15 % | GENSCRIPT BIO (01548): PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED MEMORANDUM AND ARTICLES ... | ||
| INNOVENT BIOLOGICS | 9,799 | +2,61 % | Innovent Biologics: Innovent Announces 2025 Annual Results and Business Updates | From China Leadership to Global Premier:
Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization
SAN FRANCISCO and SUZHOU, China... ► Artikel lesen | |
| QUANTUM-SI | 0,741 | -0,86 % | Quantum-Si Incorporated: Quantum-Si Announces the Start of the Proteus Roadshow | Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics... ► Artikel lesen | |
| ORIGIN AGRITECH | 1,090 | +2,83 % | Origin Agritech Limited: Origin Agritech Announces Fiscal Year 2025 Results | Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025
BEIJING, Jan. 30, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or... ► Artikel lesen | |
| SCILEX | 5,700 | -4,20 % | Scilex Holding Co - 10-K, Annual Report | ||
| AKESO | 15,195 | +2,01 % | Akeso, Inc.: Akeso Reports Full-Year 2025 Financial Results | HONG KONG, March 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 28,910 | -1,06 % | Harmony Biosciences ernennt Peter Anastasiou zum Chief Operating Officer | ||
| QIAGEN | 35,045 | +0,04 % | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| IMMUNOVANT | 24,500 | -4,48 % | IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,37 % bei einem Aktienkurs von 17,710 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.